Author

Collette McGhee

Observed names: C McGhee, C McGhee2

Observed institutions: Manchester Academic Health Science Centre, Aberdeen Royal Infirmary, Oxford Health NHS Foundation Trust, University of Manchester, University of Oxford, Manchester University NHS Foundation Trust, MRC University of Glasgow Centre for Virus Research

OpenAlex ID: A5077198272

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

2023 · Callum Jackson, Iain D Stewart, et al. · The Lancet Respiratory Medicine · 35

Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study

2023 · Omer Elneima, Hamish J C McAuley, et al. · International Journal of Epidemiology · 23

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury

2023 · Maxime Taquet, Zuzanna Skorniewska, et al. · Brain Communications · 14

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

Daily fluid intake is reduced in people with early Parkinson's disease compared with controls

2026 · IJ Sleeman1*, AD MacLeod1, et al. · Live Repository

Patients with early Parkinson’s disease report reduced fluid intake compared to controls

2025 · Isobel J. Sleeman, Angus D. MacLeod, et al. · Proceedings of The Nutrition Society

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

3123 Daily fluid intake is reduced in people with early Parkinson's disease compared with controls

2025 · I J Sleeman, A D MacLeod, et al. · Age and Ageing

Daily Fluid Intake in People With Newly Diagnosed Parkinson’s Disease Is Reduced Compared With Controls

2025 · Isobel J. Sleeman, Angus D. MacLeod, et al. · Parkinson s Disease

Works count: 11

Citation count: 164

H-index: 6

I10-index: 6